| |
Drug Discovery and Development: What We Have to Do Differently
San Diego Bio-Pharma Conference 2008
June 14th, 2008, Del Mar Hilton, Del Mar
| |
(Agenda
in PDF format for printing) |
8:00 am - 5:00 pm |
Exhibition |
8:00 am - 8:45 am |
Continental Breakfast & Registration |
8:45 am - 9:00 am |
Welcome |
|
Hui Li, Ph.D, President of SABPA SD, Senior Principal Scientist,
Pfizer Global Research & Development |
9:00 am - 10:20 am |
Session I.Innovative Approaches for Novel Medicines |
|
Sui-Xiong Cai*, Ph.D., BOD of SABPA, Senior Director of Chemistry, EpiCept Corporation |
|
Regulus Therapeutics: Pioneering A New Approach to Developing Therapeutics based on microRNAs
Balkrishen Bhat, Ph.D., Senior Director of Medicinal Chemistry, Regulus Therapeutics |
|
How to Use Nucleic Acids to Personalize Medicine
Charles Cantor, Ph.D., CSO, Sequenom |
|
Using Protein Medicinal Chemistry to Create Science and Business Value
Stephen Kaldor, Ph.D. President and CEO, Ambrx |
10:20 am -10:50 am |
Coffee Break  |
10:50 pm - 12:00 pm |
Panel Discussion I: Evolving Business Models for Bio-Pharma R&D
- Challenges and Opportunities |
|
Jack Lief* , Co-Founder, Chairman, President and CEO, Arena [slides] |
|
Stephen A. Bent* , Partner, Foley & Lardner [slides] |
|
Stan Fleming , M.B.A., Managing Member of Forward Ventures |
|
Troy Wilson , Ph.D., J.D. Co-Founder, President and CEO, Intellikine |
|
Dajun Yang , M.D., Ph.D., Managing Director, Morningside Group |
12:00 pm - 12:15 pm |
San Diego Bio-Pharma Achievement Award (To Be Announced) |
|
Hui Cai*, Ph.D., M.B.A., Chair of Board, SABPA, BOD of SDCA, Vice President of
Corporate Development, HUYA Bioscience
Award Recipient: Shu Chien, M.D., Ph.D., University Professor of Bioengineering and Medicine, UCSD
|
12:15 pm - 1:30 pm |
Luncheon  |
1:30 pm - 3:10 pm |
Session II. Future Strategies for Biomedical Research and Drug Discoveries |
|
Ming Guo*, Ph.D., BOD of SABPA, Vice President, Pharmaceutical Sciences &
Manufacturing,
General Manager, Ascenta (Shanghai) R&D Center, Ascenta Therapeutics, Inc. |
|
Small Molecule Drug Discovery in the Modern World
Mike Varney , Ph.D., VP, Small Molecule Drug Discovery, Genentech |
|
The Pfizer Incubator: Strategic Investment in Early-Stage Technologies
Mark J. Benedyk , Ph.D., Head of the Pfizer Incubator |
|
Clinical and Translation Research in Singapore: Opportunities for
Pharmaceutical, Biotechnology, and Academic Collaborations
|
| |
Judith Swain, M.D., Executive Director, the Singapore Institute for Clinical Sciences |
| |
Edward Holmes , M.D., Executive Deputy Chairman, Biomedical Research Council;
Executive Chairman, National Medical Research Council , Singapore |
3:10 pm - 3:30 pm |
Coffee Break |
3:30 pm - 4:30 pm |
Panel Discussion II: Business Opportunities in Beijing China |
|
Wei Zhou* , Ph.D., J.D., Partner, Wilson Sonsini Goodrich & Rosati, P.C.
|
| |
Beijing’s Economic Image and Investment Environment
WeiMin Zhou, M.B.A, Deputy Director of Beijing Investment Promotion Bureau |
|
The Current Industrial Development, Potential Market and the Business Opportunities
Xinxin Zhao, Deputy Director of Beijing Biotechnology Park |
| |
Speedy Generation of Antibodies for Proteomics & Biomarker Discovery
Lei Sun, Ph.D. CEO and President, AbMax Biotechnology
|
|
The State Food and Drug Administration (SFDA), China |
4:30 pm |
Closing |
|
Feng Tian, Ph.D., President of SDCA, BOD of SABPA,
Scientific Investigator, Metabasis Therapeutics, Inc. |
4:30 pm - 5:00 pm |
Networking |
|
|
|
*Moderator
Back to top
|
